Regulation of cAMP Intracellular Levels in Human Platelets Stimulated by 2‐Arachidonoylglycerol
- 13 October 2015
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 117 (5) , 1240-1249
Abstract
We demonstrated that in human platelets the endocannabinoid 2‐arachidonoylglycerol (2‐AG) decreased dose‐ and time‐dependently cAMP intracellular levels. No effect on cAMP decrease induced by 2‐AG was observed in the presence of the adenylate cyclase inhibitor SQ22536 as well in platelets pretreated with the thromboxane A2 receptor antagonist, SQ29548 or with aspirin, inhibitor of arachidonic acid metabolism through the cyclooxygenase pathway. An almost complete recovering of cAMP level was measured in platelets pretreated with the specific inhibitor of phosphodiesterase (PDE) 3A, milrinone. In platelets pretreated with LY294002 or MK2206, inhibitors of PI3K/AKT pathway, and with U73122, inhibitor of phospholipase C pathway, only a partial prevention was shown. cAMP intracellular level depends on synthesis by adenylate cyclase and hydrolysis by PDEs. In 2‐AG‐stimulated platelets adenylate cyclase activity seems to be unchanged. In contrast PDEs appear to be involved. In particular PDE3A was specifically activated, as milrinone reversed cAMP reduction by 2‐AG. 2‐AG enhanced PDE3A activity through its phosphorylation. The PI3K/AKT pathway and PKC participate to this PDE3A phosphorylation/activation mechanism as it was greatly inhibited by platelet pretreatment with LY294002, MK2206, U73122, or the PKC specific inhibitor GF109203X. Taken together these data suggest that 2‐AG potentiates its power of platelet agonist reducing cAMP intracellular level. J. Cell. Biochem. 117: 1240–1249, 2016.Keywords
Funding Information
- Ministero della Ricerca Scientifica, Italy (Cofin MIUR 2009 project no 2009 2030200605)
This publication has 47 references indexed in Scilit:
- Clopidogrel, a P2Y12 Receptor Antagonist, Potentiates the Inflammatory Response in a Rat Model of Peptidoglycan Polysaccharide-Induced ArthritisPLOS ONE, 2011
- Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activationBlood, 2011
- P2 receptors and platelet functionPurinergic Signalling, 2011
- 2‐arachidonyl glycerol activates platelets via conversion to arachidonic acid and not by direct activation of cannabinoid receptorsBritish Journal of Clinical Pharmacology, 2010
- Protein Kinase C-mediated Phosphorylation and Activation of PDE3A Regulate cAMP Levels in Human PlateletsJournal of Biological Chemistry, 2009
- Endocannabinoids and the haematological systemBritish Journal of Pharmacology, 2007
- Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3ABlood, 2007
- Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signaling complexAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Inhibition by 2-Arachidonoylglycerol, a Novel Type of Possible Neuromodulator, of the Depolarization-Induced Increase in Intracellular Free Calcium in Neuroblastoma × Glioma Hybrid NG108-15 CellsBiochemical and Biophysical Research Communications, 1997
- Stimulation by Insulin of a Serine Kinase in Human Platelets That Phosphorylates and Activates the cGMP-Inhibited cAMP PhosphodiesteraseBiochemical and Biophysical Research Communications, 1993